AVXL Investors Have Opportunity to Lead Anavex Life Sciences Corp. Securities Fraud Lawsuit

LOS ANGELES, April 22, 2024 /PRNewswire/ — Glancy Prongay & Murray LLP ("GPM") announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against Anavex Life Sciences Corp. ("Anavex" or the "Company") (NASDAQ: AVXL).


(PRNewsfoto/Glancy Prongay & Murray LLP)

Advertisements

Class Period: February 1, 2022

Full story available on Benzinga.com

See also  Getting Perspective and Dealing with Volatility

Leave a Reply

Your email address will not be published. Required fields are marked *